Universal Detection Technology Delivers Order of Bioterrorism Detection Equipment and Training Kits to the Washington, D.C. Fire and EMS Department

The Order Was Delivered to the Department's Homeland Security and Special Operations Division

• Press Release
• Source: Universal Detection Technology
• On 7:00 am EST, Wednesday January 14, 2009

LOS ANGELES, CA--(MARKET WIRE)--Jan 14, 2009 -- Universal Detection Technology (www.udetection.com) (OTC BB:UNDT.OB - News) (Frankfurt:PO8.F - News), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has delivered a bulk order for its five-agent bioterrorism detection equipment to the Washington, D.C. Fire and Emergency Medical Services (FEMS). The order was delivered directly to the department's Homeland Security and Special Operations Division. The order includes equipment capable of spot detection of anthrax, ricin toxin, botulinum toxin, plague, and SEBs, as well as kits that mimic a "suspicious powder" scenario thus preparing the first responders for a real world event.

Related Quotes Symbol Price Change PO8.F 0.00 0.00 {"s" : "po8.f,undt.ob","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The District of Columbia Fire and Emergency Medical Services Department (FEMS) is an all-hazards agency providing emergency medical care and transportation (EMS), fire prevention, fire suppression, hazardous material response, and technical rescue services to residents and visitors in the District of Columbia. FEMS resources are deployed from 33 neighborhood fire stations and include 37 EMS transport units, 33 engine companies, 16 ladder trucks, three heavy-rescue squads, one hazardous materials unit, and one fire Boat Company. 17 of these transport units and 19 of these engine companies are staffed by paramedics providing advanced life support (ALS) care. FEMS responds to over 150,000 incidents a year, an average of 421 a day. FEMS also provides protection for special events that are unique to the nation's capital, such as major demonstrations and the upcoming Presidential Inauguration. In addition, FEMS provides fire and medical protection for Presidential motorcades and helicopter landings.

UNDT's anthrax detection equipment has been extensively used by first responders and private industry throughout the country. The equipment has been evaluated by the U.S. DOD as well as the United Kingdom military. The equipment's capacities include:

 
--  No cross-reactivity with near neighbor strains
--  No cross-reactivity to household powders
--  No set up time
--  No expensive reader needed
--  No decontamination requirements
--  No false positives
--  No false negatives
--  No hook effect

"We are proud to have fulfilled our order to the DC Fire and EMS services and that our equipment will be used in securing our capital and the upcoming presidential inauguration," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer.

For more information, please visit our website at www.udetection.com or

Email us at info@udetection.com.

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit www.udetection.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

     Contact:
     Jacques Tizabi
     310-248-3655
     Email Contact